Delivery Order SPE2DB20D9331-SPE2DB24FL1L1

Award Date 7/22/24
Potential Completion Date 8/12/24
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,258.56 firm fixed-price contract is for the procurement of ADCETRIS 50 MG vials, with a period of performance through May 22, 2024. DMS Pharmaceutical Group holds a single-award, indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $44,728.26, covers the delivery of ADCETRIS 50 MG VIALS, a specialized pharmaceutical product, with a period of performance through November 30, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,314.66 contract is for the delivery of ADCETRIS 50 MG VIALS and has a completion date of December 10, 2024. DMS Pharmaceutical Group holds a large Indefinite Delivery Contract (IDC) worth up to $499,999,999 with the DLA under the SPE2DB program. This IDC allows the DLA to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $16,239.58 and covers the delivery of ADCETRIS 50 MG VIALS, a specialized pharmaceutical product, with a period of performance through February 25, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $91,887.84 contract is for the delivery of ADCETRIS 50 MG VIALS and does not have a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $45,943.92 firm fixed-price contract is for the delivery of ADCETRIS 50 MG VIALS, a specialty pharmaceutical product, with a period of performance extending to June 6, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $45,943.92, is for the delivery of ADCETRIS 50 MG VIALS, a specialized oncology medication, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a larger single-award Indefinite Delivery Contract (IDC) with...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ADCETRIS 50 MG VIALS, a pharmaceutical product, with a ceiling value of $76,573.20 and an ultimate completion date of June 6, 2024. The contract is not set-aside and is issued under a larger single-award Indefinite Delivery Contract (IDC) with DMS...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $45,943.92, is for the delivery of ADCETRIS 50 MG VIALS, a specialty oncology medication. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $45,943.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4564357709 ADCETRIS 50 MG VIALS. This Delivery Order contract is part of a larger single-award Indefinite Delivery Contract (IDC) between the DLA and DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The IDC...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB24FL1L1
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $45,943.92 and has an ultimate completion date of August 12, 2024.

The contract is for the delivery of the pharmaceutical drug ADCETRIS 50 MG VIALS and does not have a set-aside designation. DMS Pharmaceutical Group Inc. has a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide.

Generated 1/9/25, 9:23 AM